Submitted by Anonymous (not verified) on 2 December 2024 - 15:13
Human medicines European public assessment report (EPAR): Cablivi, caplacizumab, Date of authorisation: 30/08/2018, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cablivi, caplacizumab, Date of authorisation: 30/08/2018, Revision: 9, Status: Authorised